NeuroSense Therapeutics Ltd, a company developing treatments for severe neurodegenerative diseases, announced it has signed a collaboration agreement with Dr. Ghazaleh Sadri-Vakili, MS, PhD...
Cell coding company bit.bio has announced an expansion to its product portfolio - ioGlutamatergic Neurons TDP-43M337V disease model and early access to its ioMicroglia...